Parabolic Drugs Ltd - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Compliance/Disclosure requirement pursuant to Regulation 30(2) read with clause m of Sub-Part A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Parabolic Drugs Limited which was undergone through Corporate Insolvency Resolution Process (CIRP).